Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/high-sensitivity-c-reactive-protein-is-an-independent-clinical-feature-REGLD6KDvh
References (51)
-
B. Mulhall, J. Ong, Z. Younossi (2002)
Non‐alcoholic fatty liver disease: An overviewJournal of Gastroenterology and Hepatology, 17
-
Seung-Ha Park, W. Jeon, S. Kim, Hong-Joo Kim, D. Park, Y. Cho, In-Kyung Sung, C. Sohn, D. Keum, Byung-Ik Kim (2006)
Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adultsJournal of Gastroenterology and Hepatology, 21
-
J. Hui, J. Kench, S. Chitturi, A. Sud, G. Farrell, K. Byth, P. Hall, Mahbub Khan, J. George (2003)
Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis CHepatology, 38
-
S Chitturi, S Abeygunasakera, GC Farrell, J Holmes-Walker, JM Hui, C Fung (2002)
NASH and insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 35
-
(2001)
Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 285
-
A. Katsuki, Y. Sumida, Hideki Urakawa, E. Gabazza, S. Murashima, K. Morioka, N. Kitagawa, Takashi Tanaka, R. Araki-Sasaki, Y. Hori, K. Nakatani, Y. Yano, Y. Adachi (2002)
Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus.The Journal of clinical endocrinology and metabolism, 87 11
-
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
-
P. Angulo, K. Lindor (2002)
Non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 17
-
Seishi Yamada, T. Gotoh, Y. Nakashima, K. Kayaba, S. Ishikawa, N. Nago, Y. Nakamura, Y. Itoh, E. Kajii (2001)
Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study.American journal of epidemiology, 153 12
-
J. Haukeland, J. Damås, Z. Konopski, E. Løberg, T. Haaland, I. Goverud, P. Torjesen, K. Birkeland, K. Bjøro, P. Aukrust (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.Journal of hepatology, 44 6
-
R. Odbileg, S. Konnai, T. Usui, K. Ohashi, M. Onuma (2005)
Quantification of llama inflammatory cytokine mRNAs by real-time RT-PCR.The Journal of veterinary medical science, 67 2
-
J. Ludwig, T. Viggiano, D. McGill, B. Oh (1980)
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.Mayo Clinic proceedings, 55 7
-
M. Teli, O. James, A. Burt, M. Bennett, C. Day (1995)
The natural history of nonalcoholic fatty liver: A follow‐up studyHepatology, 22
-
Seung-Ha Park, Byung-Ik Kim, J. Yun, Jeong-Wook Kim, D. Park, Y. Cho, In-Kyung Sung, Chang-Young Park, C. Sohn, W. Jeon, H. Kim, E. Rhee, Won-Young Lee, Sun Kim (2004)
Insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian menJournal of Gastroenterology and Hepatology, 19
-
J. Yudkin, C. Stehouwer, J. Emeis, S. Coppack (1999)
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?Arteriosclerosis, thrombosis, and vascular biology, 19 4
-
A. Hanley, K. Williams, A. Festa, L. Wagenknecht, R. D'Agostino, S. Haffner (2005)
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.Diabetes, 54 11
-
E. Bugianesi, E. Gentilcore, R. Manini, S. Natale, E. Vanni, N. Villanova, E. David, M. Rizzetto, G. Marchesini (2005)
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver DiseaseThe American Journal of Gastroenterology, 100
-
L. Friedman, J. Dienstag, E. Watkins, C. Hinkle, J. Spiers, S. Rieder, C. Huggins (1987)
Evaluation of blood donors with elevated serum alanine aminotransferase levels.Annals of internal medicine, 107 2
-
H. Baumann, J. Gauldie (1990)
Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation.Molecular biology & medicine, 7 2
-
P. Ridker, N. Rifai, L. Rose, J. Buring, N. Cook (2002)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.The New England journal of medicine, 347 20
-
G. Farrell (2003)
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?Journal of Gastroenterology and Hepatology, 18
-
K. Promrat, G. Lutchman, G. Uwaifo, Renee Freedman, A. Soza, T. Heller, E. Doo, M. Ghany, A. Premkumar, Y. Park, T. Liang, J. Yanovski, D. Kleiner, J. Hoofnagle (2004)
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitisHepatology, 39
-
M. Rutter, J. Meigs, L. Sullivan, R. D'Agostino, P. Wilson (2004)
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 110
-
P. Ridker, M. Stampfer, N. Rifai (2001)
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.JAMA, 285 19
-
P. Ridker, N. Rifai, M. Clearfield, J. Downs, S. Weis, J. Miles, A. Gotto (2001)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.The New England journal of medicine, 344 26
-
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, J. Gallimore, M. Pepys (2000)
Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesBMJ : British Medical Journal, 321
-
P. Ridker, N. Rifai, M. Pfeffer, F. Sacks, L. Moye, S. Goldman, G. Flaker, E. Braunwald (1998)
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.Circulation, 98 9
-
T. Ono, N. Shiga, Y. Taneda, S. Umemura (1999)
The Fasting-plasma Glucose Range in which Insulin Resistance Measured by Homeostasis Model Assessment Correlates with Euglycemic Clamping, 42
-
S. Liangpunsakul, N. Chalasani (2005)
Unexplained Elevations in Alanine Aminotransferase in Individuals with the Metabolic Syndrome: Results from the Third National Health and Nutrition Survey (NHANES III)The American Journal of the Medical Sciences, 329
-
A. Sanyal (2002)
Treatment of non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 17
-
W. Koenig, M. Sund, M. Fröhlich, H. Fischer, H. Löwel, A. Döring, W. Hutchinson, M. Pepys (1999)
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.Circulation, 99 2
-
E. Brunt (2001)
Nonalcoholic Steatohepatitis: Definition and PathologySEMINARS IN LIVER DISEASE,, 21
-
P. Angulo (2002)
Nonalcoholic fatty liver disease.Revista de gastroenterologia de Mexico, 70 Suppl 3
-
JM Hui, A Hodge, GC Farrell, JG Kench, A Kriketos, J George (2004)
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?Hepatology, 40
-
J. Clark, A. Diehl (2003)
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.JAMA, 289 22
-
L. Adams, P. Angulo, K. Lindor (2005)
Nonalcoholic fatty liver diseaseCanadian Medical Association Journal, 172
-
P. Ridker, C. Hennekens, Julie Buring, N. Rifai (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.The New England journal of medicine, 342 12
-
T. Iwasaki, A. Nakajima, M. Yoneda, Y. Terauchi (2006)
Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.Endocrine journal, 53 3
-
K. Alberti, P. Zimmet (1998)
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 15
-
P Angulo, KD Lindor (2002)
Non-alcoholic fatty liver diseaseJ Gastroenterol Hepatol, 17
-
N. Sattar, A. Gaw, O. Scherbakova, I. Ford, D. O’Reilly, S. Haffner, C. Isles, P. Macfarlane, C. Packard, S. Cobbe, J. Shepherd (2003)
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention StudyCirculation: Journal of the American Heart Association, 108
-
A. Hak, C. Stehouwer, M. Bots, K. Polderman, C. Schalkwijk, I. Westendorp, A. Hofman, J. Witteman (1999)
Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.Arteriosclerosis, thrombosis, and vascular biology, 19 8
-
S. Kurioka, Y. Murakami, M. Nishiki, M. Sohmiya, K. Koshimura, Y. Kato (2002)
Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus.Endocrine journal, 49 4
-
A. Diehl, A. Diehl, Z. Goodman, Z. Goodman, K. Ishak, K. Ishak (1988)
Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.Gastroenterology, 95 4
-
C. Matteoni, Z. Younossi, T. Gramlich, N. Boparai, Yao‐Chang Liu, A. McCullough (1999)
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.Gastroenterology, 116 6
-
P Angulo (2002)
Nonalcoholic fatty liver diseaseN Engl J Med, 18
-
C. Lorenzo, Mayor Okoloise, K. Williams, M. Stern, S. Haffner (2003)
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.Diabetes care, 26 11
-
P. Ridker, M. Cushman, M. Stampfer, R. Tracy, C. Hennekens (1997)
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.The New England journal of medicine, 336 14
-
T. Yoshizumi, Tadashi Nakamura, M. Yamane, A. Islam, M. Menju, K. Yamasaki, Takeshi Arai, K. Kotani, T. Funahashi, S. Yamashita, Yuji Matsuzawa (1999)
Abdominal fat: standardized technique for measurement at CT.Radiology, 211 1
-
J. Hui, A. Hodge, G. Farrell, J. Kench, A. Kriketos, J. George (2004)
Beyond insulin resistance in NASH: TNF‐α or adiponectin?Hepatology, 40
-
S. Chitturi, S. Abeygunasekera, G. Farrell, J. Holmes-Walker, J. Hui, C. Fung, R. Karim, R. Lin, D. Samarasinghe, C. Liddle, M. Weltman, J. George (2002)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 35
- Publisher
- Springer Journals
- Copyright
- Copyright © 2007 by Springer-Verlag Tokyo
- Subject
- Medicine & Public Health; Gastroenterology; Oncology; Surgical Oncology; Hepatology; Internal Medicine; Colorectal Surgery
- ISSN
- 0944-1174
- eISSN
- 1435-5922
- DOI
- 10.1007/s00535-007-2060-x
- pmid
- 17653654
- Publisher site
- See Article on Publisher Site
Abstract
This is the first report to demonstrate consistent and profound elevation of hs-CRP in cases of NASH compared with in cases of simple nonprogressive steatosis. Our results suggest that hs-CRP may be a clinical feature that not only distinguishes NASH from simple nonprogressive steatosis but also indicates the severity of hepatic fibrosis in cases of NASH.
Journal
Journal of Gastroenterology – Springer Journals
Published: Jul 25, 2007